KHDRBS1 and breast carcinoma: Silencing of Sam68 in the breast cancer cell lines have also shown inhibition of cell proliferation and anchorage-independent growth, up-regulation of cyclin-dependent kinase inhibitors, increased FOXO transcriptional activity and deactivation of the PI3K/Akt pathway [24].